Dissemination of intraperitoneal ovarian cancer: Discussion of mechanisms and demonstration of lymphatic spreading in ovarian cancer model

2009 ◽  
Vol 72 (1) ◽  
pp. 1-9 ◽  
Author(s):  
Anis Feki ◽  
Philip Berardi ◽  
Geoff Bellingan ◽  
Attila Major ◽  
Karl-Heinz Krause ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Cancer Model ◽  
Lymphatic Spreading

Cytotoxic lymphocytes, interferon, and tumor rejection in the peritoneal cavity of a murine ovarian cancer model using immunotherapy with biologic response modifiers

1983 ◽  
Vol 15 (1) ◽  
pp. 136
Author(s):  
Jonathan S. Berek ◽  
Neville F. Hacker ◽  
Jacob Zighelboim ◽  
Alan Lichtenstein ◽  
Reba Knox ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Peritoneal Cavity ◽  
Tumor Rejection ◽  
Cytotoxic Lymphocytes ◽  
Cancer Model ◽  
Biologic Response

scholarly journals Phosphatidylcholine-specific phospholipase C inhibition reduces HER2-overexpression, cell proliferation andin vivotumor growth in a highly tumorigenic ovarian cancer model

Oncotarget ◽  
2017 ◽  
Vol 8 (33) ◽  
pp. 55022-55038 ◽  
Author(s):  
Luisa Paris ◽  
Franca Podo ◽  
Francesca Spadaro ◽  
Laura Abalsamo ◽  
Maria Elena Pisanu ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Cell Proliferation ◽  
Phospholipase C ◽  
Her2 Overexpression ◽  
Cancer Model

Abstract 325: Characterization and evaluation of a mouse ovarian cancer model for its preclinical suitability.

2013 ◽  
Author(s):  
Sungpil Cho ◽  
Yongen Sun ◽  
Andrew P. Soisson ◽  
Mark K. Dodson ◽  
C. Matthew Peterson ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Cancer Model

Abstract B33: Understanding resistance mechanisms to PI3K/mTOR inhibitors in ovarian cancer model systems

2015 ◽  
Author(s):  
Ghassan Tashkandi ◽  
Alexey Goltsov ◽  
Peter Mullen ◽  
Jim Bown ◽  
David Harrison ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Mtor Inhibitors ◽  
Resistance Mechanisms ◽  
Model Systems ◽  
Cancer Model

Abstract A28: A comparison of a DNA-sourced neoantigen vaccine to an RNA-sourced frameshift vaccine in the mouse ovarian cancer model

2020 ◽  
Author(s):  
Milene Tavares Batista ◽  
Sierra Murphy ◽  
John Lainson ◽  
Lui Shen ◽  
Stephen Johnston
Keyword(s):  
Ovarian Cancer ◽  
Cancer Model

scholarly journals Defining a murine ovarian cancer model for the evaluation of conditionally-replicative adenovirus (CRAd) virotherapy agents

2019 ◽  
Vol 12 (1) ◽  
Author(s):  
Rebeca González-Pastor ◽  
Ahmad Mohammad Ashshi ◽  
Adel Galal El-Shemi ◽  
Igor P. Dmitriev ◽  
Elena A. Kashentseva ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Cancer Model ◽  
Conditionally Replicative Adenovirus

Inhibition of PORCN in a p53-/- knockout syngeneic ovarian cancer model

2020 ◽  
Vol 159 ◽  
pp. 93
Author(s):  
W. Goldsberry ◽  
J.A. Wall ◽  
S. Meza-Perez ◽  
A.A. Katre ◽  
A.I. Londono ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Cancer Model

scholarly journals PDT Dose Parameters Impact Tumoricidal Durability and Cell Death Pathways in a 3D Ovarian Cancer Model

2013 ◽  
Vol 89 (4) ◽  
pp. 942-952 ◽  
Author(s):  
Imran Rizvi ◽  
Sriram Anbil ◽  
Nermina Alagic ◽  
Jonathan P. Celli ◽  
Lei Zak Zheng ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Cell Death ◽  
Cancer Model ◽  
Cell Death Pathways
Sign in / Sign up

Export Citation Format

Share Document